Results 211 to 220 of about 219,641 (298)

Human Recreation and Fire History Shape Landscape Connectivity for an Endangered Forest Carnivore

Animal Conservation, EarlyView.
Roads and trails can impede wildlife movement, but their permeability varies with human use and fire history. We combined GPS telemetry from 45 endangered southern Sierra Nevada fishers (Pekania pennanti) with smartphone‐derived human mobility data to estimate crossing probability across road and trail segments. Fishers were about 2.5 times more likely
Mark A. Ditmer, Maksim Sergeyev, Helen E. Chmura, Jody M. Tucker, Gavin M. Jones, Kari E. Norman, Ronan B. Hart, Michael K. Schwartz, Andria M. Townsend, Rebecca E. Green, Sarah L. Stock, George Wittemyer   +11 more
wiley   +1 more source

Short-term ketamine interventions for depressive disorders: practical best-practice recommendations for psychiatrists using oral, subcutaneous, and nasal formulations. [PDF]

Front Psychiatry
Słupska A, Cubała WJ, Swieczkowski D, Szarmach J, Słupski J, Włodarczyk A.   +5 more
europepmc   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Comment on "Ketamine and rebound pain after regional nerve block: Methodological considerations". [PDF]

Indian J Anaesth
Prasad A.
europepmc   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Procedural Sedation in Pediatric Gastroenterology: A Narrative Review from the Shared Perspective of Pediatric Gastroenterology and Anesthesiology. [PDF]

Children (Basel)
Cesur S, Uyar Aksu N, Uncuoğlu A, Çardaközü T, İçli D.   +4 more
europepmc   +1 more source

The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Ketamine assisted psychotherapy is a promising new treatment for alcohol use disorder (AUD). The psychoactive effects of repeated intravenous (IV) ketamine infusions in people with AUD and their mechanistic role in treating AUD are largely unknown.
Cassie Bloy, Ananya Sarma, Bethan Marsh, Lorna Hardy, Meryem Grabski, Merve Mollaahmetoglu, Joshua Shotton, Shamhethan Bhaskaran, Anne Lingford‐Hughes, H. Val Curran, Celia Morgan, Will Lawn   +11 more
wiley   +1 more source